A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101)

Clinical trial NCT02028065 · COMPLETED

Trial details

NCT number: NCT02028065
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypersensitivity Anaphylaxis

Start date: 2014-01-03
Primary completion: 2014-07-01
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.